Seymour welcomes Medsafe's year-on-year approvals improvement

August 21, 2025 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

“Assessment timeframes for most categories of medicine are now similar to the timeframes required in Australia. We often use compare ourselves to Australia, and in this area we have caught up,” said Associate Health Minister David Seymour. …

Subscribe now to continue reading.

Latest Video

The lesson to learn from the Guild is that you cannot defeat what you do not know
December 14, 2025 - Latest News
Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis
December 15, 2025 - Latest News
GBMA to host inaugural summit aimed at addressing medicine shortages
December 15, 2025 - Latest News
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - Latest News
Novartis names new Country President following leadership transition
December 16, 2025 - Latest News

Seymour welcomes Medsafe's year-on-year approvals improvement

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

New Stories

OncoSil completes first production run at new Sydney manufacturing facility

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response

Sign In

Seymour welcomes Medsafe's year-on-year approvals improvement

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Novartis names new Country President following leadership transition

Follow Us

New Stories

OncoSil completes first production run at new Sydney manufacturing facility

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response